New Frontiers in Drug Discovery: Academia Meets Industry at the International Helmholtz Drug Discovery Conference (HDDC).

Biomedical Research Chemistry, Pharmaceutical Drug Discovery Drug Industry Germany Humans

Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
05 03 2020
Historique:
pubmed: 23 2 2020
medline: 10 4 2021
entrez: 22 2 2020
Statut: ppublish

Résumé

The Helmholtz Drug Discovery conference HDDC 2018 was held on April 26-27, 2018 at the Helmholtz Zentrum in Munich, Germany. The meeting covered a wide range of topics. Keynote lectures were presented by 17 internationally renowned speakers from Europe and the US, and an additional 11 talks were selected from 70 submitted abstracts. With over 220 participants, there was overwhelming response and interest by researchers from both academia and industry.

Identifiants

DOI: 10.1002/cmdc.202000019 PMID: 32080972
pubmed: 32080972
doi: 10.1002/cmdc.202000019
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

468-470

Informations de copyright

© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Martin Göttlicher (M)

Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Institute of Toxicology and Environmental Hygiene, Technische Universität München, Biedersteiner Straße 29, 80802, München, Germany.

Michael Sattler (M)

Institute of Structural Biology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.
Chair Biomolecular NMR-Spectroscopy, Bayerisches NMR Zentrum Department Chemie, Technische Universität München, Ernst-Otto-Fischer-Straße 2, 85748, Garching, Germany.
ORCID: 0000-0002-1594-0527

Mark Brönstrup (M)

Department of Chemical Biology, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124, Braunschweig, Germany.
Biomolecular Drug Research Center (BMWZ) Institute of Organic Chemistry, Leibniz Universität Hannover, Schneiderberg 38, 30167, Hannover, Germany.
ORCID: 0000-0002-8971-7045

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Recherche biomédicale › New Frontiers in Drug Discovery: Academia...
questionsmedicales.fr › Disciplines des sciences naturelles › Chimie › Chimie pharmaceutique › New Frontiers in Drug Discovery: Academia...
questionsmedicales.fr › Techniques d'investigation › Développement de médicament › Découverte de médicament › New Frontiers in Drug Discovery: Academia...
questionsmedicales.fr › Technologie, industrie et agriculture › Industrie › Secteur secondaire › Industrie pharmaceutique › New Frontiers in Drug Discovery: Academia...
questionsmedicales.fr › Régions géographiques › Europe › Allemagne › New Frontiers in Drug Discovery: Academia...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › New Frontiers in Drug Discovery: Academia...